ddrg/super_eurlex huggingface dataset:
Official Journal of the European Union

Prior notification of a concentration

(Case M.10118 — Investindustrial/Guala Closures)

(Text with EEA relevance)

(2021/C 65/07)

1. On 17 February 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Special Packaging Solutions Investment S.à.r.l. (‘SPSI’, Luxembourg), controlled by Investindustrial S.A. (‘Investindustrial’, Luxembourg), — Guala Closure S.p.A. (‘Guala’, Italy). SPSI acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control over Guala. The concentration is accomplished by way of purchase of shares and a public bid announced on 8 December 2020.

2. The business activities of the undertakings concerned are: — for Investindustrial: group of independently managed investment, holding and financial advisory companies focused on investments in medium-sized companies based in Europe. Investindustrial’s portfolio focuses on three main investment areas: consumer and leisure; healthcare and services; and industrial manufacturing, — for Guala: production of non-refillable and aluminium closures for spirits, wine, oil and vinegar, water, and beverages.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10118 — Investindustrial/Guala Closures Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Official Journal of the European Union

Prior notification of a concentration

(Case M.10090 — Abu Dhabi Developmental Holding Company/Louis Dreyfus Commodities and Energy Holdings/Louis Dreyfus)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 80/06)

1. On 1 March 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Abu Dhabi Developmental Holding Company PJSC (‘ADQ’, United Arab Emirates), — Louis Dreyfus Commodities and Energy Holdings N.V. (‘LDCEH’, Netherlands), controlled by Akira Holding Foundation, — Louis Dreyfus Company B.V. (‘LDC’, Netherlands), currently solely controlled by LDCEH. ADQ and LDCEH acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of LDC. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for ADQ: holding company with investments in a number of sectors, including food and agriculture, financial services, industries, logistics, and transport. — for LDCEH: financial holding company. — for LDC: holding company of the Louis Dreyfus Company group of companies, operating as a merchant and processor of agricultural goods, with activities spanning the entire value chain (origination, production, processing, refining, storing, transporting, researching, merchandising, customising, distributing).

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10090 — Abu Dhabi Developmental Holding Company/Louis Dreyfus Commodities and Energy Holdings/Louis Dreyfus Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9981 — Bain Capital/Ahlstrom-Munksjö)

(Text with EEA relevance)

(2021/C 73/01)

On 8 January 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M9981. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10028 — Black Diamond Capital Management/Investindustrial Group/Phenolic Specialty Resins Business of Hexion)

(Text with EEA relevance)

(2021/C 89/01)

On 19 January 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10028. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9187 — Autolaunch/Beijing Electric Vehicle Co/JVs)

(Text with EEA relevance)

(2021/C 82/05)

On 21 December 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9187. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10133 — Astorg/Nordic Capital/Novo/Bioclinica)

(Text with EEA relevance)

(2021/C 99/11)

1. On 16 March 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Astorg Asset Management S.à r.l. (‘Astorg’, Luxembourg) — Nordic Capital IX Limited (‘Nordic Capital’, Jersey) — Novo Holdings A/S (‘Novo’, Denmark) — Bioclinica Holding I LP (‘Bioclinica’, USA) Astorg, Nordic Capital and Novo acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Bioclinica through eResearch Technology, Inc (‘ERT’, USA). The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are the following: — for Astorg: a global private equity firm, — for Nordic Capital: a private equity firm focused on healthcare, technology & payments, financial services, and industrial & business services, — for Novo: a holding company responsible for the management of the assets of the Novo Nordisk Foundation through investments in the life sciences and related areas and through minority investments of a financial and venture capital nature, — Astorg, Nordic Capital, and Novo jointly control ERT, a provider of software-enabled clinical research solutions, — for Bioclinica: a provider of software-enabled clinical research solutions, including medical imaging and cardiac safety services, clinical adjudication, randomization and trial supply management and optimization solutions, electronic and eSource data capture, clinical trial management software, and drug safety solutions.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10133 — Astorg/Nordic Capital/Novo/Bioclinica Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.10148 — FCA/EEPS/JV)

(Text with EEA relevance)

(2021/C 91/02)

On 12 March 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10148. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9945 — Siemens Healthineers/Varian Medical Systems)

(Text with EEA relevance)

(2021/C 121/02)

On 19 February 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M9945. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

Case M.10164 – CVC/Stark Group

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 113/07)

1. On 23 March 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — CVC Capital Partners SICAV-FIS S.A. (‘CVC’, Luxembourg) — STARK Group A/S (‘Stark’, Denmark) CVC acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of Stark. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for CVC: CVC and its subsidiaries manage investment funds and platforms. In particular, CVC owns Ahlsell AB, which is active in the retail and distribution of installation products for heating, ventilation and air-conditioning, electricals, tools and supplies, as well as building materials. — for Stark: retail sale and distribution of building materials in Denmark, Finland, Germany, Norway and Sweden.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10164 – CVC/Stark Group Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10199 — Goldman Sachs/Advania)

(Text with EEA relevance)

(2021/C 136/02)

On 6 April 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10199. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10209 — Ceravis/Fraunhofer-Gesellschaft/E-VITA JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 130/05)

1. On 7 April 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Ceravis AG (‘Ceravis’, Germany), belonging to Danish Agro Group (‘Danish Agro’, Denmark), — Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (‘Fraunhofer-Gesellschaft’, Germany), — E-VITA GmbH (‘E-VITA’, Germany). Ceravis and Fraunhofer-Gesellschaft acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation control of E-VITA. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — for Ceravis: agricultural trade as well as production of seeds and animal feed, primarily for farmers in the northern German states of Schleswig-Holstein and Mecklenburg-Vorpommern. Danish Agro is a cooperative farm supply company, — for Fraunhofer-Gesellschaft: application-oriented research as well as contract research for government agencies and the private sector in various scientific fields, — for E-VITA: marketing, use, distribution and further development of electron technology for chemical-free seed treatment.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10209 — Ceravis/Fraunhofer-Gesellschaft/E-VITA JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10245 — TA Associates/Partners Group/Unit4)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 154/12)

1. On 23 April 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — TA Associates Management L.P. (‘TA Associates’, USA) — Partners Group AG (‘Partners Group’, Switzerland) — Unit4 NV (‘Unit4’, The Netherlands). TA Associates and Partners Group acquire within the meaning of Articles 3(1)(b) and 3(4) of the Merger Regulation joint control of the whole of Unit4. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for TA Associates: private equity investments in five core sectors, namely the technology, financial services, healthcare, consumer, and business services industries in North America, Europe and Asia. — for Partners Group: global private markets investment management in the areas of private equity, private real estate, private infrastructure and private debt in companies in various industries. — for Unit4: business software and IT services, focusing on the provision of enterprise resource planning (‘ERP’) software solutions.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10245 – TA Associates/Partners Group/Unit4 Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10090 — Abu Dhabi Developmental Holding Company/Louis Dreyfus Commodities and Energy Holdings/Louis Dreyfus)

(Text with EEA relevance)

(2021/C 143/01)

On 7 April 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10090. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10237 — Bridgepoint/Infinigate)

(Text with EEA relevance)

(2021/C 184/01)

On 6 May 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10237. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.